Cargando…

Epidemiology of Hepatitis B and C in Republic of Indonesia

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections pose serious problems in terms of public health and clinical intervention in a country with approximately 250 million people, who live in more than 17,000 islands. Efforts to combat HBV and HCV have been made through the implementation o...

Descripción completa

Detalles Bibliográficos
Autor principal: H Muljono, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663775/
https://www.ncbi.nlm.nih.gov/pubmed/29201773
http://dx.doi.org/10.5005/jp-journals-l0018-1212
_version_ 1783274878000955392
author H Muljono, David
author_facet H Muljono, David
author_sort H Muljono, David
collection PubMed
description Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections pose serious problems in terms of public health and clinical intervention in a country with approximately 250 million people, who live in more than 17,000 islands. Efforts to combat HBV and HCV have been made through the implementation of universal infant hepatitis B immunization, blood screening, and other health promotion actions, and building epidemiological data to develop intervention strategies. A nationwide study in 2013 revealed hepatitis B surface antigen (HBsAg) prevalence of 7.1%, which indicates that Indonesia has moved from high to moderate endemicity of hepatitis B, leaving the prevalence of 9.4% in 2007. The occurrences of new hepatitis B cases still continue in early childhood period, which may root from low coverage of birth-dose hepatitis B immunization in remote islands, and the potential mother-to-child transmission of HBV from HBsAg-positive pregnant mothers. Other problems still exist including the high HBV infection rates among young adults in remote islands, the presence of occult hepatitis B, as well as the substantial prevalence of HCV infection in general population, who do not have access to diagnosis and treatment. Effective preventive and control strategies are being developed tailored to the local capacity, infrastructures, socioeconomics, and culture, as well as geographical aspects of the country. How to cite this article: Muljono DH. Epidemiology of Hepatitis B and C in Republic of Indonesia. Euroasian J Hepato-Gastroenterol 2017;7(1):55-59.
format Online
Article
Text
id pubmed-5663775
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-56637752017-11-30 Epidemiology of Hepatitis B and C in Republic of Indonesia H Muljono, David Euroasian J Hepatogastroenterol Mini Review Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections pose serious problems in terms of public health and clinical intervention in a country with approximately 250 million people, who live in more than 17,000 islands. Efforts to combat HBV and HCV have been made through the implementation of universal infant hepatitis B immunization, blood screening, and other health promotion actions, and building epidemiological data to develop intervention strategies. A nationwide study in 2013 revealed hepatitis B surface antigen (HBsAg) prevalence of 7.1%, which indicates that Indonesia has moved from high to moderate endemicity of hepatitis B, leaving the prevalence of 9.4% in 2007. The occurrences of new hepatitis B cases still continue in early childhood period, which may root from low coverage of birth-dose hepatitis B immunization in remote islands, and the potential mother-to-child transmission of HBV from HBsAg-positive pregnant mothers. Other problems still exist including the high HBV infection rates among young adults in remote islands, the presence of occult hepatitis B, as well as the substantial prevalence of HCV infection in general population, who do not have access to diagnosis and treatment. Effective preventive and control strategies are being developed tailored to the local capacity, infrastructures, socioeconomics, and culture, as well as geographical aspects of the country. How to cite this article: Muljono DH. Epidemiology of Hepatitis B and C in Republic of Indonesia. Euroasian J Hepato-Gastroenterol 2017;7(1):55-59. Jaypee Brothers Medical Publishers 2017 2017-05-05 /pmc/articles/PMC5663775/ /pubmed/29201773 http://dx.doi.org/10.5005/jp-journals-l0018-1212 Text en Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Mini Review
H Muljono, David
Epidemiology of Hepatitis B and C in Republic of Indonesia
title Epidemiology of Hepatitis B and C in Republic of Indonesia
title_full Epidemiology of Hepatitis B and C in Republic of Indonesia
title_fullStr Epidemiology of Hepatitis B and C in Republic of Indonesia
title_full_unstemmed Epidemiology of Hepatitis B and C in Republic of Indonesia
title_short Epidemiology of Hepatitis B and C in Republic of Indonesia
title_sort epidemiology of hepatitis b and c in republic of indonesia
topic Mini Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663775/
https://www.ncbi.nlm.nih.gov/pubmed/29201773
http://dx.doi.org/10.5005/jp-journals-l0018-1212
work_keys_str_mv AT hmuljonodavid epidemiologyofhepatitisbandcinrepublicofindonesia